MTOR and breast cancer: To explore the potential biological function modulated by sEV proteins, GSVA was conducted and indicated that some cancer‐associated pathways were enriched in T‐sEVs (Figure S1D), including the PI3K‐AKT‐mTOR, DNA repair and MYC target pathways, which are commonly aberrantly activated in BC.28